153 related articles for article (PubMed ID: 36975425)
21. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
22. Association between long-term erectile dysfunction and biochemical recurrence after permanent seed I(125) implant brachytherapy for prostate cancer. A longitudinal study of a single-institution.
Morgia G; Castelli T; Privitera S; Al-Nakib C; Favilla V; Marchese F; Cimino S; Russo GI
Aging Male; 2016; 19(1):15-9. PubMed ID: 26376010
[TBL] [Abstract][Full Text] [Related]
23. Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy.
Boehle A; Katic K; König IR; Robrahn-Nitschke I; Brandenburg B
Brachytherapy; 2020; 19(1):24-32. PubMed ID: 31629640
[TBL] [Abstract][Full Text] [Related]
24. Dosimetry and cancer control after low-dose-rate prostate brachytherapy.
Robert Lee W; Deguzman AF; McMullen KP; McCullough DL
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):52-9. PubMed ID: 15629593
[TBL] [Abstract][Full Text] [Related]
25. Radical prostatectomy versus high dose permanent prostate brachytherapy using iodine-125 seeds for patients with high risk prostate cancer: a matched cohort analysis.
Park DS; Gong IH; Choi DK; Hwang JH; Shin HS; Oh JJ
World J Urol; 2013 Dec; 31(6):1511-7. PubMed ID: 23624718
[TBL] [Abstract][Full Text] [Related]
26. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
[TBL] [Abstract][Full Text] [Related]
27.
Zhou Z; Yan W; Zhou Y; Zhang F; Li H; Ji Z
Oncol Lett; 2019 Jul; 18(1):72-80. PubMed ID: 31289474
[TBL] [Abstract][Full Text] [Related]
28. Combined-modality
Boehle A; Katic K; König IR; Robrahn-Nitschke I; Renner P; Brandenburg B
World J Urol; 2019 Nov; 37(11):2355-2363. PubMed ID: 30707304
[TBL] [Abstract][Full Text] [Related]
29. Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer.
Goy BW; Burchette R; Soper MS; Chang T; Cosmatos HA
Urology; 2020 Feb; 136():180-189. PubMed ID: 31704459
[TBL] [Abstract][Full Text] [Related]
30. [Long-term evaluation of low-dose-rate (LDR) brachytherapy in localized prostate cancer].
Carl N; Rassweiler J; Andreas J; Carl S
Urologie; 2023 Oct; 62(10):1057-1063. PubMed ID: 37256413
[TBL] [Abstract][Full Text] [Related]
31. The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions.
Tanaka N; Asakawa I; Katayama E; Hirayama A; Hasegawa M; Konishi N; Fujimoto K
Radiat Oncol; 2014 May; 9():107. PubMed ID: 24885896
[TBL] [Abstract][Full Text] [Related]
32. Relationship between Day 0 dosimetric parameters and biochemical relapse-free survival in patients treated with transperineal permanent prostate interstitial brachytherapy with (125)I seeds.
Garrán C; Ciérvide R; Cambeiro M; Moreno-Jiménez M; Ramos LI; Martínez-Monge R
Brachytherapy; 2010; 9(1):8-14. PubMed ID: 19846350
[TBL] [Abstract][Full Text] [Related]
33. Patterns of recurrence after low-dose-rate prostate brachytherapy: a population-based study of 2223 consecutive low- and intermediate-risk patients.
Lo AC; Morris WJ; Pickles T; Keyes M; McKenzie M; Tyldesley S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):745-51. PubMed ID: 25752387
[TBL] [Abstract][Full Text] [Related]
34. Manual vs. automated implantation of seeds in prostate brachytherapy: Oncologic results from a single-center study.
Thomas L; Chemin A; Leduc N; Belhomme S; Rich E; Lasbareilles O; Giraud A; Descat E; Roubaud G; Sargos P
Brachytherapy; 2018; 17(1):214-220. PubMed ID: 29102738
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
[TBL] [Abstract][Full Text] [Related]
36. Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.
Hamilton SN; Tyldesley S; Hamm J; Jiang WN; Keyes M; Pickles T; Lapointe V; Kahnamelli A; McKenzie M; Miller S; Morris WJ
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):934-41. PubMed ID: 25240272
[TBL] [Abstract][Full Text] [Related]
37. [Quality of life after brachytherapy or robot-assisted radical prostatectomy for localized prostate cancer].
Martín-López JE; Rodríguez-López R; Romero-Tabares A; Beltran-Calvo C; Molina-López T; Baena-González V
Arch Esp Urol; 2015 Mar; 68(2):142-51. PubMed ID: 25774821
[TBL] [Abstract][Full Text] [Related]
38. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience.
Sylvester JE; Grimm PD; Wong J; Galbreath RW; Merrick G; Blasko JC
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):376-81. PubMed ID: 20864269
[TBL] [Abstract][Full Text] [Related]
39. Radical prostatectomy versus external-beam radiotherapy for localized prostate cancer: long-term effect on biochemical control-in search of the optimal treatment.
González-San Segundo C; Herranz-Amo F; Alvarez-González A; Cuesta-Álvaro P; Gómez-Espi M; Paños-Fagundo E; Santos-Miranda JA
Ann Surg Oncol; 2011 Oct; 18(10):2980-7. PubMed ID: 21431406
[TBL] [Abstract][Full Text] [Related]
40. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC
Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
